We randomly allocated 2332 eligible adult patients ( 18 years of age ) with an indication for drug-eluting stent implantation to the zotarolimus-eluting Endeavor Sprint stent ( Medtronic , Santa Rosa , CA , USA ) or the sirolimus-eluting Cypher Select Plus stent ( Cordis , Johnson & Johnson , Warren , NJ , USA ) .